SPDR S&P Biotech ETF (NYSEARCA:XBI) Stock Holdings Reduced by Intellectus Partners LLC

Intellectus Partners LLC reduced its position in SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) by 5.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,739 shares of the exchange traded fund’s stock after selling 595 shares during the period. Intellectus Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $1,061,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Quintet Private Bank Europe S.A. acquired a new position in SPDR S&P Biotech ETF in the third quarter worth approximately $40,000. ORG Partners LLC bought a new stake in SPDR S&P Biotech ETF in the second quarter worth approximately $40,000. ORG Wealth Partners LLC acquired a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth $44,000. Waldron Private Wealth LLC bought a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at $54,000. Finally, Resources Management Corp CT ADV lifted its stake in shares of SPDR S&P Biotech ETF by 30.3% in the 2nd quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock valued at $55,000 after purchasing an additional 138 shares during the last quarter.

SPDR S&P Biotech ETF Trading Down 3.0 %

Shares of NYSEARCA:XBI opened at $96.96 on Friday. The stock has a market capitalization of $7.39 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 1 year low of $69.32 and a 1 year high of $105.47. The firm has a fifty day moving average price of $99.04 and a 200 day moving average price of $95.99.

SPDR S&P Biotech ETF Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Read More

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.